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Aims. Our group investigated albumin gene expression in human adipocytes, its regulation by inﬂammation and the possible
contribution of adipose tissue to albumin circulating levels. Methods. Both inﬂamed and healthy subjects provided adipose
tissue samples. RT-PCR, Real-Time PCR, and Western Blot analysis on homogenates of adipocytes and pre-adipocytes were
performed. In sixty-three healthy subjects and ﬁfty-four micro-inﬂamed end stage renal disease (ESRD) patients circulating levels
of albumin were measured by nephelometry; all subjects were also evaluated for body composition, calculated from bioelectrical
measurements and an thropometric data. Results. A clear gene expression of albumin was showed in pre-adipocytes and, for
the ﬁrst time, in mature adipocytes. Albumin gene expression resulted signiﬁcantly higher in pre-adipocytes than in adipocytes.
No signiﬁcant diﬀerence in albumin gene expression was showed between healthy controls and inﬂamed patients. A signiﬁcant
negative correlation was observed between albumin levels and fat mass in both healthy subjects and inﬂamed ESRD patients.
Conclusions. In the present study we found ﬁrst time evidence that human adipocytes express albumin. Our results also showed
that systemic inﬂammation does not modulate albumin gene expression. The negative correlation between albumin and fat mass
seems to exclude a signiﬁcant contributing role of adipocyte in plasma albumin.
1.Introduction
Adipose tissue, once just believed a passive organ storing
excess energy, is now considered a real endocrine organ,
with an important role in the regulation of homeostatic
systems [1]. It secretes various proteins that can be classiﬁed
into molecules acting on metabolic processes like glucose
homeostasis and insulin sensitivity, and into inﬂammatory
molecules like interleukin 6 (IL-6), interleukin 1β,T u m o r
Necrosis Factor-α, C-reactive protein (C-RP), Leptin, and
Adiponectin [2]. The adipose tissue may account for 20–
25% of systemic IL-6 circulating levels [3] and seems to be
involved in the systemic inﬂammatory response associated
with obesity, insulin resistance, and metabolic syndrome [4].
On this basis, adipose tissue represents a new and fas-
cinating multidisciplinary object of research. We previously
found a clear expression of IL-6 receptors and C-reactive
protein in human adipocytes obtained from adipose tissue
fragments of diﬀerent districts (subcutaneous and omental
of noninﬂamed and inﬂamed patients), showing that the
adipose tissue, and in particular the adipocyte, was not only
responsible for generating an inﬂammatory state per se but
it also represents a target, by itself, of systemic inﬂammation
[5]. We observed, in fact, that the adipocyte, stimulated by
IL-6 through its cell receptor produces C-RP, as it happens in
the hepatocyte.
Adipose tissue is a mesodermallyderived organ that con-
tains, in addition to adipocytes, a stromal population2 Mediators of Inﬂammation
composed by diﬀerent cell types, such as pre-adipocytes,
stem cells, ﬁbroblasts, and macrophages. Mature adipocytes
account for only 40–60% of the whole cell population
whatever the type of adipose tissue [6]. Pre-adipocytes
are present throughout adult life in adipose tissue and
can proliferate and diﬀerentiate into mature adipocytes,
accordingtotheenergybalance;theyalsosharesomefeatures
with macrophages, such as the capacity of phagocytosis in
response to diﬀerent stimuli [7]. Another important cell
population of the adipose tissue is represented by mes-
enchymal stem cells (MSCs) that are adherent, ﬁbroblast-
like, pluripotent, and nonhematopoietic progenitor cells.
These cells retain the capacity to undergo into many
mesenchymal cell types, including bone cells [8, 9], neuronal
cells [10], adipose [11], and muscular [12]t i s s u ein vitro,
a n do fn o t e ,i n t oh e p a t o c y t e - l i k ec e l l s[ 13–15]. Thereby,
both the pre-adipocyte, with a very restricted potential,
and the multipotent mesenchymal cell represent adipocyte
precursors.
Albumin, normally produced by the hepatocyte, is the
most abundantly circulating protein in blood, where it plays
an important role as binding protein and is involved in the
regulation of colloid-osmotic homeostasis [16]. Circulating
half-life of plasma albumin is 19 to 21 days. It is also a
negative acute phase protein and hypoalbuminemia is the
result of the combined eﬀects of inﬂammation, through
inhibitory cytokine (especially IL-6), and inadequate protein
and caloric intake in patients with chronic inﬂammatory
disease, such as chronic renal failure [17] where it represents
a cardiovascular risk factor [18].
Considered the well-known active role of adipocyte in C-
RP production and the presumable link between adipocyte
and hepatocyte, we aimed this study at investigating if
mature adipocytes express the gene of albumin and at
evaluating whether systemic inﬂammation might regulate
this expression, as we previously found for C-RP [5].
Furthermore, we speculated whether the adipocyte might
contribute to the total circulating levels of albumin, as it
happens for IL-6.
2. Methods
2.1. Quantization of Albumin mRNA and Protein Presence in
Adipocytes and Preadipocytes
2.1.1.Patientsand Healthy Controls Selection andAdipose Tis-
sue Samples. Human subcutaneous adipose tissue samples
wereobtainedfromtwelvesubjectsdividedintwosubgroups
on the basis of a preliminary evaluation of C-RP circulating
levels. According to Pepys and Hirschﬁeld [19]w ea s s u m e d
a cut-oﬀ level of 3mg/L, in order to discriminate between
inﬂamed and noninﬂamed patients. On the basis of C-RP
values, we obtained a group of six healthy (noninﬂamed)
subjects, without any clinical symptoms or sign of inﬂam-
mation, who underwent minor surgery procedures and a
group of six patients with chronic inﬂammatory disease who
underwent elective surgical procedures: (a) four for cancer
and (b) two patients operated for cholecystectomy.
Allenrolledsubjectsprovidedwritten,informedconsent,
andtheEthicsCommitteeofourhospitalapprovedthestudy.
To avoid a possible confounding inﬂammatory eﬀect
exerted by obesity or overweight status, inﬂamed patients
andnoninﬂamedcontrolswereBMImatchedinbothgroups
of subjects. The presence of other systemic diseases (vasculi-
tis, rheumatoid arthritis, osteoarthritis, and bowel or lung
inﬂammatory disease) was excluded in all subjects (excepted
malignancy); in particular, before the deﬁnitive inclusion,
the possible existence of any immunological disease, malig-
nancy (in the healthy group), and infectious disease was
carefully investigated and excluded. No patient was diabetic
and none assumed steroid or immunosuppressive therapy.
Bloodsampleswerecollected,beforesurgicalprocedures,
from all studied subjects to obtain serum aliquots. Sera
were stored at −80◦C until C-RP and IL-6 assays were
performed. Adipose tissue biopsies were obtained during the
surgicalproceduresinall12subjectsandforeachpatientwas
obtained a sample of subcutaneous total white adipose tissue
and a sample of omental adipose tissue. After removal, to
get rid of tissue debris the bioptic material was washed twice
with warm sterile 0.9% NaCl solution; then the sample was
immediately frozen in liquid nitrogen and stored at −80◦C
until RNA extraction.
2.1.2. C-Reactive Protein (C-RP) Assay. C-RP circulating
levels were determined by a high-sensitivity ELISA assay
(Bender MedSystems, Vienna, Austria) on serum aliquots
of all subjects included in the study. The lower detection
limit was 3pg/mL, and the overall intra-assay coeﬃcient of
variation has been calculated to be 6.9%. All samples were
analyzed in duplicate.
2.1.3. IL-6 Assay. The concentrations of IL-6 in plasma
samples were analyzed by ELISA using a commercially
available kit (Quantikine; R&D Systems, Minneapolis, MN),
as described elsewhere [20]. The lower detection limit of IL-
6 assay was <0.70pg/mL, and the coeﬃcient of variation
of both inter- and intra-assay was <5%. All samples were
analyzed in duplicate.
2.1.4. Isolation of Adipocytes, Stromal Cells, and Preadipocytes
from Adipose Tissue Fragments. Adipose tissue fragments
obtained from the six noninﬂamed subjects and from
the six inﬂamed patients were placed in 37◦C, sterile
0.9% NaCl, 5.6mM glucose, and 25mM HEPES buﬀer
with pH adjusted to 7.4 and containing 50Upenicillin/mL
plus 50mg streptomycin/mL. The adipose tissue fragments
were minced under sterile conditions and digested in
Krebs-Ringer bicarbonate buﬀer supplemented with 5.6mM
glucose, 50Upenicillin/mL, 50mg streptomycin/mL, and
17mg type I collagenase/10g adipose tissue (Worthington
Biochemical, Lakewood, NJ). Digestion was for 75min at
37◦C, with rotary agitation at 40rpm. The isolated cells
were ﬁltered through a single layer of chiﬀon, and the
isolated adipocytes were allowed to ﬂoat for 5min at 37◦C.
The ﬂuid under the ﬂoating adipocytes (containing stromal
fraction) was transferred to a conical polypropylene 50-mLMediators of Inﬂammation 3
centrifuge tube. For the adipocytes, 1mL of cell suspension
of adipose cells was suspended in each tube containing
speciﬁcadipocytemedium(Zen-Bio,ResearchTrianglePark,
NC) and incubated in the speciﬁc conditions until the cell
lysis process. The stromal fraction was centrifuged at 800g
for 10min.
For the isolation of pre-adipocytes, we ﬁrst centrifuged
the cell pellet at 800×g for 10 minutes and then we washed
three times with Dulbecco’s modiﬁed Eagle medium: nutri-
ent mixture F-12 (Ham) in combination 01:01 (DMEM:
F12, Gibco-BRL, Carlsbad, California), which has been
supplemented to give 15-mM NaHCO3, penicillin 50-U: mL
streptomycin and 50mg: mL. After washing, the pellet was
resuspended by trituration in DMEM supplemented pre-
adipocyte: F12 containing 10% fetal bovine serum (FBS,
Gibco-BRL, Carlsbad, CA). The cells were then plated and
incubated in a humidiﬁed incubator at 37◦Ci na na t m o -
sphere of 5% CO2 in air for 24 hours to allow attachment
and proliferation of cells. After 24 hours, the medium was
removed and replaced by speciﬁc pre-adipocyte medium
(Zen-Bio, Inc., Research Triangle Park, NC) and subculture.
2.1.5. Identiﬁcation of Primers for Albumin and β-Actin. The
genome sequences corresponding to Albumin and β-Actin
were obtained from GeneBank (http://www.ncbi.nlm.nih
.gov/) to identify speciﬁc primers. We analyzed the exon
sequences to establish a pair of primers (sense and antisense)
able to generate ampliﬁed fragments measuring between 150
and 700bp in length, with annealing temperature between
55 and 62◦C. The sense and antisense primers were selected
to include at least one intron to prevent genomic DNA
contamination during ampliﬁcation. The selected primer is
shown in Table 1.
2.1.6. RNA Isolation and Expression Analysis by Reverse Tran-
scription-Polymerase Chain Reaction (RT-PCR). The isolated
c ellsw e r epul v e riz edwithab le nd e r .T otalRN Awase xtract ed
by the guanidinium thiocyanate technique. Four μgo ft o t a l
RNA were subjected to cDNA synthesis for 1h at 37◦C
using the “Ready to go You-Primer First-Strand Beads” kit
(Amersham Pharmacia Biotech, Piscataway, NJ, code 27-
9264-01) in a reaction mixture containing 0.5μg oligo-
dT (Amersham Pharmacia Biotech cod. 27-7610-01). PCR
ampliﬁcation of cDNA was performed in a reaction mixture
containing 4μL of cDNA sample and diﬀerent primer sets
(20p/mol each). The ampliﬁcation of Albumin gene and
human β-actin gene, as an internal control, was achieved
using 2 primer sets. After an initial denaturation at 94◦C
for 5min, PCR reactions were carried out using 30 cycles
of 94◦C for 1min, the temperature for annealing for 1min,
and 72◦C for 1min in a Perkin Elmer Cetus 480 thermal
cycler (Perkin Elmer). PCR products were separated by
gel electrophoresis on a 2% agarose gel and stained with
ethidium bromide. The bands obtained were quantiﬁed by
densitometric analysis. All signals were normalized to the
mRNA levels of the housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase and expressed as a ratio.
2.1.7. Real-Time PCR. Real-time quantitative PCR analysis
for albumin gene was performed on cell lysate (both adi-
pocytesandstromalfraction)usingABIprism7500(Applied
Biosystems, Foster City, CA) and the 5-exonuclease assay
(TaqMan technology). The cDNA, synthesized as described
above, was used for real-time PCR performed in 96-well
optical reaction plates with cDNA equivalent of 100ng of
RNA in a volume of 25μL reaction containing 1x Taqman
Universal Master Mix, optimized concentrations of FAM-
labeled probe, and speciﬁc forward and reverse primer for
Albumin gene from Assay on Demand (Applied Biosystems).
ControlsincludedRNAsubjectedtoRT-PCRwithoutreverse
transcriptase and PCR with water replacing cDNA. The
results were analyzed using a comparative method, and
the values were normalized to the β-actin expression and
converted into fold change based on a doubling of PCR
product in each PCR cycle according to the manufacturer’s
guidelines, as previously described.
2.1.8. Western Blot. Homogenates of adipocytes and pread-
ipocytes were prepared in radioimmune precipitation assay
buﬀer (1X PBS, 1% NP-40, 0.5% sodium deoxycholate,
0.1% SDS containing phenylmethylsulfonyl ﬂuoride, aprot-
inin, sodium orthovanadate and protease inhibitor tablet)
(completeTM Mini, Boehringer-Mannheim) containing an-
tipain dihydrochloride (50mg/mL), bestatin (40mg/mL),
chymostatin (60mg/mL), E-64 (10mg/mL), leupeptin
(0.5mg/mL), pepstatin (0.7mg/mL), phosphoramidon
(300mg/mL), Pefabloc SC (1mg/mL), EDTA disodium salt
(0.5mg/mL), and aprotinin (2mg/mL)]. The cells were
centrifuged at 14,000 ×gf o r3 0 m i na t4 ◦Ca n dp r o t e i n
concentrations were determined with the Bradford assay
[21] using bovine serum albumin as a standard. For im-
munoblotting, protein (100μg) was subjected to 8% SDS-
polyacrylamidegelelectrophoresis.Proteinsweretransferred
to polyvinylidene diﬂuoride (PVDF) membranes at a
constant voltage of 200V for 16h. The PVDF membranes
were blocked for 1h in 5% nonfat dried milk in TBS-0.1%
tween buﬀer (25mM Tris-HCl, 0.2mM NaCl; 0.1% Tween
20 (v/v) pH 7.6) (TBST). The membrane was washed 2X
with TBST and then incubated overnight at 4◦C with the
respective primary antibodies. Albumin antibody was from
Cell Signaling (Beverly, MA); GADPH antibodies were
obtained from Santa Cruz Biotechnology. After extensive
washing of membrane with TBST buﬀer, anti-rabbit
immunoglobulin conjugated with horseradish peroxidase
was added at a 1:5000 dilution and incubated for 1h at
room temperature. An enhanced chemiluminescence kit
(Amersham, NJ) was used to identify protein expression.
2.2. Measurement of Albumin and Body Fat Mass in Healthy
and Inﬂamed Patients. In sixty-three healthy (noninﬂamed)
subjects and ﬁfty-four microinﬂamed (C-RP: 5.24 ±
2.26mg/L) ESRD patients undergoing RDT we determined
circulating albumin levels (by nephelometry), Body Weight
(BW) to the nearest 50g (by using a calibrated balance
beam scale), Body Mass Index (BMI), calculated as the4 Mediators of Inﬂammation
Table 1
Primers Sense Antisense
ALBUMIN CTTGAATGTGCTGATGACAGG GCAAGTCAGCAGGCATCTCAT
β-ACTIN CACCATGGATGATGATATCG TGGATAGCAACGTACATGG
Oligonucleotide sequences designed for this study.
ratio body weight/height2 (in kg/m2), and body compo-
sition, assessed by conventional bioelectrical impedance
analysis (BIA) and by bioelectrical impedance vector anal-
ysis (BIVA), as previously described [22]. Resistance (R)
and reactance (Xc) were measured by a single-frequency
50kHz bioelectrical impedance analyzer (BIA 101 RJL,
Akern Bioresearch, Firenze, Italy) according to the standard
tetrapolar technique, by applying the software provided by
the manufacturer, which incorporated validated predictive
equations for total body water (TBW), fat mass (FM), fat
free mass (FFM), and extracellular water (ECW) [23, 24].
T h es a m ei n v e s t i g a t o r sp e r f o r m e da n t h r o p o m e t r ya n dB I A
measurements. Soft tissue hydration of individual subjects
was evaluated by BIVA. R and Xc were normalized by the
height of subjects (R/H and Xc/H) and the resulting vectors
were plotted on a graph reporting the gender-speciﬁc 50th,
75th, and 95th tolerance ellipses of similar vectors calculated
from a reference healthy population. According to the RXc
graph method, vectors falling within the reference gender-
speciﬁc 75th tolerance ellipse indicated normal hydration;
short vectors (below the lower pole of the 75th tolerance
ellipse) indicated overhydration and long vectors (above the
upper pole of the 75th tolerance ellipse) indicated under-
hydration [25]. The length of the vector was calculated as
|Z|=
√
[(R/H)2 + (Xc/H)2] and the phase angle of the
vector as the arctan of Xc/R.
2.3. Statistical Analysis. Statistical analysis was performed by
using unpaired t-test and ANOVA (followed by Bonferroni
post hoc test) and linear regression analysis. Results are
expressed as means ± SD; statistical signiﬁcance was deﬁned
as P<0.05.
3. Results
3.1. Quantization of Albumin mRNA and Protein in
Adipocytes and Preadipocytes
3.1.1. Patients Selection and Adipose Tissue Samples. Demo-
graphic, anthropometric, and biochemical baseline data of
all enrolled subjects are reported in Table 2. No signiﬁcant
diﬀerence was observed in sex, age, body weight, BMI, waist
circumference, and waist-to-hip ratio between the two dif-
ferent groups. On the contrary, plasma C-RP and IL-6 levels
were much higher in patients with chronic inﬂammatory
diseases than in healthy (noninﬂamed) subjects (P<0.01).
3.1.2. Albumin Gene Expression by RT-PCR in the Adipocyte
and Preadipocyte. RT-PCR showed that the adipocytes
extracted from all the districts of adipose tissue (omental
β-Actin
β-Actin
Sc-n Om-n
Sc-inﬂ Om-inﬂ
Albumin
Albumin
Figure 1: Albumin gene expression obtained by RT-PCR in
subcutaneous (Sc) and Omental (Om) adipocytes from normal
healthy subjects (Sc-n and Om-n, resp.) and inﬂamed patients (Sc-
inﬂ and Om-inﬂ, resp.). β-Actin gene expression is also reported as
housekeeping. The image is representative of all the experiments.
and subcutaneous) of noninﬂamed controls and inﬂamed
patientsexpressedthegeneofalbumin(Figure 1);themRNA
for this marker was found in the adipocytes and pre-
adipocytes of all fragments of adipose tissue.
3.1.3. Albumin Gene Expression by Real-Time PCR in the
Adipocyte and Preadipocyte. We did not ﬁnd any statistically
signiﬁcant diﬀerence in albumin gene expression between
inﬂamed and noninﬂamed patients in adipocytes drawn
from both Sc and Om adipose tissue. As Figure 2 shows,
we only observed an higher omental adipocyte albumin
than subcutaneous one in each group. We concluded that
inﬂammation does not modulate albumin gene expression
in the adipocyte, but probably further studies are required
to conﬁrm this result. Figure 3 shows the diﬀerent albumin
gene expression, studied by real-time PCR, in adipocytes and
pre-adipocytes obtained from either Sc or Om fragments
of adipose tissue drawn from noninﬂamed subjects. Pre-
adipocyte albumin gene expression was higher then the
adipocyte one in both Om and Sc fragments and this
diﬀerence was statistically signiﬁcant. We also observed that
albumingeneexpressioninthepre-adipocyte extractedfrom
fragments of Om adipose tissue was signiﬁcantly higher than
in preadipocyte from Sc fragments. No diﬀerence was found
between the adipocytes from diﬀerent districts (Figure 3).
3.1.4. Albumin Protein Expression in the Adipocytes and
Preadipocytes Obtained from the Diﬀerent Types of Adipose
Tissue Studied by Western Blot. Finally, we investigated
whether at the protein level adipocytes and pre-adipocyte
were also able to express albumin in all the subjects. As
shown in Figures 4 and 5, Western Blot analyses showed theMediators of Inﬂammation 5
Table 2: Demographic and anthropometric characteristics of the 12 subjects who underwent the adipose tissue biopsy.
Noninﬂamed subjects Chronic inﬂamed patients P value
N 66 N S
Sex (M/F) 4/2 3/3 NS
Age, yr (range) 43.2 ±4.0 (39–48) 42.9 ±3.9 (34–49) NS
Body weight, kg (range) 74.8 ±10.6 (62.9–88.2) 75.3 ±11.1 (63.2–90.7) NS
BMI, kg/m2 (range) 25.8 ± 1.6 (24.8–28.1) 26.3 ±1.2 (24.6–28.7) NS
Waist circumf., cm (range) 90.9 ±4.6 (83–106) 92.1 ±6.1 (79–108) NS
Waist-to-hip ratio (range) 0.82 ±0.11 (0.53–1.21) 0.88 ±0.15 (0.65 ±1.28) NS
C - R P ,m g / L( r a n g e ) 2 .18 ±0.54 (1.6–3.0) 7.26 ±3.26 (4.1–14.6) P<0.01
IL-6, pg/mL (range) 2.79 ±1.26 (1.3–4.9) 25.19 ±11.85 (10.3–40.3) P<0.01
Values are expressed as means ± SD; M, male; F, female; NS, not signiﬁcant; C-RP, C-reactive protein.
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Figure 2: Albumin gene expression in theadipocytes from diﬀerent
sites of adipose tissue, obtained by real-time PCR analysis. The
columns show the relative expression of albumin mRNA in
subcutaneous (Sc, gray bars) and omental (Om, black bars) adipose
tissue fragments of healthy noninﬂamed subjects (Sc-n and Om-n,
resp.) compared with those obtained in both Sc and Om adipose
tissue of inﬂamed patients (Sc-inﬂ and Om-inﬂ, resp.). The values
on the y-axis represent arbitrary units derived from the mean
expression value for albumin gene. Values are expressed in arbitrary
units as means ± S.D. of 12 experiments. ∗P< 0.05 compared with
Sc-inﬂ and Sc-n.
presence of albumin in both adipocytes and pre-adipocytes
suggesting that both adipocytes and pre-adipocytes can
synthesize albumin in Sc as well as in visceral adipose tissue,
both in healthy noninﬂamed subjects and inﬂamed patients.
3.2. Correlations between Albumin Circulating Levels and Fat
Mass in Both Noninﬂamed Subjects and Inﬂamed Patients.
We ﬁrst investigated the relationship between plasma Albu-
m i nl e v e l sa n db o d yf a tm a s s( F M )i n6 3h e a l t h ys u b j e c t s
who underwent BIA excluding from statistical analysis over-
and hypohydrated subjects (vectors falling below the lower
pole or vectors falling above the upper pole of the 75%
tolerance ellipse) evaluated by BIVA method. As shown
in Figure 6, a signiﬁcant negative correlation was observed
between plasma albumin levels and FM (R =− 0.312,
P<0.05 (2-tailed)). Plasma albumin concentrations were
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Figure 3: Albumin gene expression in the adipocytes and pre-
adipocytes from diﬀerent sites of adipose tissue of a single
noninﬂamed subject, as representative of six experiments for all the
subjects enrolled, obtained by real-time PCR analysis. The columns
showtherelativeexpressionofalbuminmRNAinSc(graybars)and
Om (black bars) adipocyte (Sc-AD and Om-AD) and preadipocyte
(PreAD) of a single healthy subject, as representative. The values
on the y-axis represent arbitrary units derived from the mean
expression value for albumin gene.
signiﬁcantly lower in those subjects with higher fat mass.
Then, we studied the same relationship in 54 microinﬂamed
ESRD patients undergoing regular dialysis therapy (RDT).
As shown in Figure 7, a signiﬁcant negative correlation was
observed between plasma albumin levels and FM (R =
−0.391, P<0.01 (2-tailed)). Plasma albumin concentrations
were signiﬁcantly lower in those ESRD patients with higher
fat mass.
4. Discussion
Albumin is the most abundant plasma protein produced
by liver cells. To date, no data are present in the literature
on albumin expression in mature adipocytes. In the present
study, we found, for the ﬁrst time, a clear albumin expression
in human mature adipocytes. In addition, on the basis of
our results, we can also reasonably aﬃrm that diﬀerentiated
adipocytes are probably able to synthesize albumin.6 Mediators of Inﬂammation
Adipocytes Preadipocytes
Om Sc Om Sc
Albumin
Actin
Figure 4: Representative immunoblot shows the albumin expres-
sion in Om and Sc adipocytes and preadipocytes isolated from a
noninﬂamed control. Actin was used as loading control.
Adipocytes Preadipocytes
Om Sc Om Sc Om Sc Om Sc
Actin
NOR INF NOR INF
Albumin
Figure 5: Representative immunoblot shows the albumin expres-
sion in Om and Sc adipocytes and preadipocytes isolated from both
inﬂamed patients (INF) and noninﬂamed controls (NOR). Actin
was used as loading control.
Albumin gene expression resulted signiﬁcantly lower in
theadipocytesthaninthepre-adipocytes;inparticular,itwas
42 e 12 times lower in Om and Sc adipocyte, respectively,
as compared with the pre-adipocyte (Figure 3). In this way,
the omental pre-adipocyte represents the most active cell in
albumin gene expression.
The presence of albumin in the pre-adipocyte is not a
novelty. In fact, Yoo and Lee investigated the role of albumin
in adipocyte diﬀerentiation, by using pre-adipocytes cell
lines such as 3T3-L1 [26]. This is a developmental pro-
cess by which undiﬀerentiated precursor cells diﬀerentiate
into mature adipocytes with coordinated changes in cell
morphology and gene expression. They found that albumin
gene expression was signiﬁcantly increased at later stages
of adipocyte diﬀerentiation process and its suppression
signiﬁcantly inhibited lipid droplet formation [26]. The
author suggests that albumin could be necessary to stabilize
lipid accumulation in mature adipocyte, probably through a
directinteractionwithfattyacids.However,itisimportantto
underline that these experiments were performed on murine
cell lines and their results cannot correspond to human cell
data.
In a previous paper, we studied the involvement of
adipose cells in patients with chronic inﬂammatory disease.
We found that not only C-RP gene expression was activated
in adipocyte cells, but both IL-6 and IL-6 receptors gene
expressions were found to be higher in inﬂamed patients
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Figure 6: Negative relationship between Albumin circulating levels
and Fat Mass. The Albumin circulating levels and Fat Mass were
measured in 63 noninﬂamed patients. Correlation is signiﬁcant at
the 0.05 level (2-tailed). R =− 0.312.
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Figure 7: Negative relationship between Albumin circulating levels
and Fat Mass. The Albumin circulating levels and Fat Mass were
measured in 54 inﬂamed ESRD (End-Stage Renal Disease) patients.
Correlation is signiﬁcant at the 0.01 level (2-tailed). R =− 0.391.
than in controls, either in subcutaneous or intra-abdominal
adipose tissue [5].
At this regard, in the present study we hypothesized
that adipocytes, similarly to hepatocytes, show a diﬀerent
albumin gene expression in inﬂamed and noninﬂamed
patients, with a lower gene expression in inﬂamed ones.
However, our results showed no signiﬁcant diﬀerence in
albumingeneexpressionbetweeninﬂamedandnoninﬂamed
patients when analyzed by Real-Time PCR (Figure 2). On
the other hand, Figure 2 shows also that albumin gene
expression was signiﬁcantly higher in intra-abdominal than
in subcutaneous adipocytes (Figure 2).
Albumin presence, as protein, together with gene expres-
sion in adipocytes raises the hypothesis that adipose tissue
contribute to circulating albumin levels, as well as it happens
for IL-6 [3]. To verify this hypothesis we evaluated the
relationshipbetweenserumalbuminandfatmass,supposing
that higher fat mass corresponds to higher circulating
albumin levels. However, our results did not conﬁrm this
hypothesis, but we found a negative signiﬁcant correlation
between albumin and fat mass both in healthy noninﬂamed
subjects and inﬂamed ESRD patients, in contrast with whatMediators of Inﬂammation 7
we expected (Figures 6 and 7). In other words, the higher
thefatmassthelowerwasserumalbuminconcentrationwas.
We suppose that higher fat mass leads to higher production
of diﬀerent proinﬂammatory cytokines, mainly IL-6, that
can downregulate albumin, production in hepatocyte via
endocrine way, independently of systemic inﬂammation. We
also suppose that IL-6 produced by adipocyte could down-
regulate, via an autocrine and/or paracrine signaling, albu-
min gene expression and production in the adipocyte itself.
This mechanism could explain both the lack of modulation
of albumin gene expression by systemic inﬂammation in the
adipocyte and the negative correlation between fat mass and
albumin levels either in noninﬂamed subjects or in inﬂamed
ESRD patients. On the contrary, this mechanism could not
operate with inﬂammatory proteins, such as C-RP [5].
Despite the lack of albumin gene modulation by inﬂam-
mation, in this study something really new was observed:
the human adipocyte, once considered a simply depot cell,
is now seen as a new and active cell, that in parallel with
hepatocyte, is able to produce diﬀerent proteins, such as C-
RP and, as novelty, albumin.
Why adipocyte shows hepatocyte-like activity is still un-
known. The more fascinating hypothesis states the existence
of a continuum in adipose tissue cell population that goes
from multipotent stem cell to more mature progenitor
pools [6], passing through the pre-adipocyte. This hypoth-
esis might explain why adipocyte and hepatocyte share
the expression of some genes, such as albumin gene. As
above mentioned, adipose-tissue-derived MSC (ADMSC)
displayed the capacity to diﬀerentiate into numerous cell
types (muscular, neuronal, bone, adipose cells) and, interest-
ingly, into hepatocyte-like cells [13–15]. A study showed that
ADMSC could be diﬀerentiated into functional hepatocyte-
like cells by the treatment of cytokine mixtures in vitro [16],
sotobecomeapotentialsourcetohepatocyteregenerationor
liver cell transplantation [27]. In another work, the authors
showed that the undiﬀerentiated na¨ ıve ADMSC were also
positive for albumin, G-6-P, and α-1-antitrypsin (AAT),
which are all known to be predominantly expressed in adult
liver cells [28].
However, we do suppose that other, more fascinating
mechanisms, apart from sharing the same origin, may ex-
plain why, to date, adipocyte and hepatocyte produce a so
important protein in our organism, like albumin.
In conclusion, this preliminary study highlights for the
ﬁrst time a new adipocyte activity, among the others already
known;howeverfurtherinvestigationsareneededtoconﬁrm
and explain our results.
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